Clinical trial
Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C
NCT00917358 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pegylated Interferon Alfa-2a for Dialysis Patients With Acute Hepatitis C
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- July 31, 2005
- Completion date
- June 30, 2008
- Enrollment
- 42 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.